Welcome

Patient Capital and Impatient Journalists

A small article in this Sunday Times’ Money section summed up a lot of what I think is wrong with the asset management industry. Having begun by stating that “it is early days yet for an investment trust marketed on the basis that it should be bought only on a 10-year view”, the column goes on immediately […]

If Buffett were British…

There was an an interesting post by Total Return Investor a few months ago in which he had a go at cloning Neil Woodford’s portfolio with US-based companies. That started me thinking about whether British investors could do something similar to create their own mini-Berkshire Hathaway. Obviously valuation is always key when buying shares and I am not suggesting that […]

Battle Against Cancer Investment Trust: Doing Good by Doing Well

There is not much in the City that does not involve generous remuneration for all involved, but the Battle Against Cancer Investment Trust (BACIT) is one rare example. This is a fund of funds that, rather than collecting different types and layers of fees for its managers, waives one layer of fees completely and donates the other to the Institute […]

Berkshire AGM – A little of the fallout

As always, there has been adoring media coverage of the Berkshire Hathaway AGM but, putting to one side the footage of WB chugging away merrily on Cherry Cokes and arm-wrestling footballers, there were two nuggets that provided me with food for thought. Bill Gates and IBM Perhaps I have been naïve, but I had always assumed that, given both […]

AstraZeneca – AGM 2015

Treating myself to a well-earned day off work yesterday, I decided to take the opportunity to attend my first corporate Annual General Meeting. Nominee Accounts Up to this point I had never been entirely confident that I could do this, because I hold my shares electronically through a nominee account. The benefits of this are that it both makes “trading” cheaper […]